Robotic Versus Laparoscopic Low Anterior Resection for Rectal Cancer: A Randomized Study
| Registry | NCT03209076, acronym RAR |
|---|---|
| Status | Unknown |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 120 (Estimated) |
| Sponsor | Instituto Nacional de Cancer, Brazil (Other gov); collaborators: Hospital de Câncer de Barretos, Hospital dos Servidores do Estado do Rio de Janeiro |
| Conditions | Rectal Neoplasms, Sexual Dysfunction, Urinary Incontinence, Quality of Life |
| Interventions | Robotic, Laparoscopic (Procedure) |
| Dates | start 2018-02-01, primary completion 2020-06-01 (estimated), completion 2020-12-01 (estimated), first posted 2017-07-06, last updated 2019-10-16 |
| Locations | 1 site in Brazil |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Rectal Neoplasms All trials for Sexual Dysfunction All trials of Robotic All trials of Laparoscopic
Prospective randomized trial comparing robotic versus laparoscopic Low anterior resection for rectal cancer.
Primary endpoint: Compare urinary dysfunction between robotic and laparoscopic approach.
Prospective randomized trial comparing robotic versus laparoscopic Low anterior resection for rectal cancer.
The Aim of the study is to compare two surgical approaches (robotic versus laparoscopic) for rectal cancer treatment regarding functional outcomes (sexual and urinary dysfunctions), quality of life, post operative outcomes and oncologic outcomes.
Patients with the diagnosis of T3 mid and low rectal cancer will be randomized to robotic or laparoscopic procedure after neoadjuvant chemoradiation. Quality of life questionnaires and Urodynamic test will be applied before and after the surgical procedures.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Robotic | Experimental | Procedure: Robotic | Robotic low anterior resection |
| Laparoscopic | Active comparator | Procedure: Laparoscopic | Laparoscopic low anterior resection |
Sex: All, ages: 18 Years to 70 Years
Inclusion Criteria: * Mid or low Rectal Adenocarcinoma * Performance Status (ECOG) 0 - 2 Exclusion Criteria: * Metastatic disease * Congestive heart failure * Renal failure * Diabetes * Pregnancy * Neurologic disorders * Alfa blockers user * Patients who are candidates to APR ( Abdomino-perineal resection)
| Facility | City | Country | Status |
|---|---|---|---|
| Instituto Nacional de Câncer- INCA | Rio de Janeiro, Rio de Janeiro | Brazil | Recruiting |